Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Ritlecitinib is safe and may effectively treat alopecia areata.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Pexidartinib often causes liver issues and fatigue, especially in women.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.